Press Start: The Game Hub in Flemingsberg – Finally!

On April 24th, after just two months of hard work, it was finally time for the kick-off for the game cluster Press Start. The initiative is led by Drivhuset, in close collaboration with Flemingsberg Science Foundation and Södertörn University’s Innovation Station.

“Press Start’s vision is to become the hub for game development in Flemingsberg – a place where serious games are not just created, but developed to drive innovation forward. We’re building a cross-sector environment where creative industries, life science, and deep tech converge. By putting entrepreneurship at the center from day one, we’re shaping the future of the gaming industry – more innovative, dynamic, and sustainable.”
– Leslie Alfredsson, Drivhuset Stockholm, Cluster Developer for Press Start

Press Start is here for the aspiring hobby coder, the freshly graduated game developer, and anyone dreaming of a career in gaming. Press Start hosts regular meet-ups where you can test new games, get feedback on your own projects, and connect with key figures in the industry.

A huge step forward in our vision to become a center for game development. The future starts here!

Join Press Start here >

Cellaviva: improving lives through stem cell technology

“Cellaviva was founded by researchers from Karolinska Institutet, in the belief that stem cells will revolutionize how complex and incurable diseases are treated. We are a biobank that helps expectant parents to save stem cells from the umbilical cord at birth, in a so-called family bank. The aim is to make high-quality, potent cells available quickly, if medical needs arise. This creates treatment opportunities and expands therapy options for the whole family,”

NextCell to treat type 1 diabetes in children with stem cells

NextCell Pharma in Flemingsberg has published extremely promising results from its clinical studies of drug candidate ProTrans for the treatment of type 1 diabetes. A study is now being carried out with the aim of examining its efficacy in children and young people.

Go to Top